---
figid: PMC2898136__nihms-210716-f0006
figlink: /pmc/articles/PMC2898136/figure/F6/
number: F6
caption: Pro-inflammatory prostaglandin E2 (PGE2) and/or B4 LTB4 promote angiogenesis
  on at least two levels. First, PGE2 and/or LTB4 can directly act on epithelial,
  endothelial and/or immune cells to induce angiogenic factors such as vascular endothelial
  growth factor (VEGF), fibroblast growth factor 2 (FGF2) and the chemokines CXCL1
  and CCL2. In transformed epithelial cells, PGE2 induces VEGF and CXCL1 secretion
  through an EP2 or EP4–epidermal growth factor (EGFR)–Erk cascade. In endothelial
  cells, PGE2 induces VEGF and FGF2 secretion through a MAPK pathway and LTB4 also
  stimulates VEGF expression. Moreover, PGE2 not only binds to endothelial cells to
  stimulate cell migration through an αVβ3 integrin–CDC42 and Rac pathway, but also
  mediates VEGF-and FGF2-induced CXCR4-dependent neovessel assembly in vivo. In immune
  cells, PGE2 promotes mast cells to release VEGF and CCL2, and LTB4 stimulates VEGF
  expression. Secretion of VEGF and FGF2 from tumour epithelial, endothelial and immune
  cells promotes endothelial cell proliferation and survival, and the chemokine CXCL1
  released from tumour epithelial cells stimulates endothelial cell migration and
  tube formation in vitro and angiogenesis in vivo. CCL2 can attract endothelial cells
  to the tumour microenvironment. Interestingly, VEGF and FGF2 induce COX2 and subsequently
  PGE2 in endothelial cells, and CCL2 also induces COX2 and PGE2 in macrophages. Therefore,
  the effects of PGE2 on the regulation of VEGF, FGF2 and CCL2 are probably amplified
  through this positive feedback loop.
pmcid: PMC2898136
papertitle: Eicosanoids and cancer.
reftext: Dingzhi Wang, et al. Nat Rev Cancer. ;10(3):181-193.
pmc_ranked_result_index: '200815'
pathway_score: 0.9701631
filename: nihms-210716-f0006.jpg
figtitle: Eicosanoids and cancer
year: ''
organisms: Homo sapiens
ndex: a6fe4b8d-dec8-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2898136__nihms-210716-f0006.html
  '@type': Dataset
  description: Pro-inflammatory prostaglandin E2 (PGE2) and/or B4 LTB4 promote angiogenesis
    on at least two levels. First, PGE2 and/or LTB4 can directly act on epithelial,
    endothelial and/or immune cells to induce angiogenic factors such as vascular
    endothelial growth factor (VEGF), fibroblast growth factor 2 (FGF2) and the chemokines
    CXCL1 and CCL2. In transformed epithelial cells, PGE2 induces VEGF and CXCL1 secretion
    through an EP2 or EP4–epidermal growth factor (EGFR)–Erk cascade. In endothelial
    cells, PGE2 induces VEGF and FGF2 secretion through a MAPK pathway and LTB4 also
    stimulates VEGF expression. Moreover, PGE2 not only binds to endothelial cells
    to stimulate cell migration through an αVβ3 integrin–CDC42 and Rac pathway, but
    also mediates VEGF-and FGF2-induced CXCR4-dependent neovessel assembly in vivo.
    In immune cells, PGE2 promotes mast cells to release VEGF and CCL2, and LTB4 stimulates
    VEGF expression. Secretion of VEGF and FGF2 from tumour epithelial, endothelial
    and immune cells promotes endothelial cell proliferation and survival, and the
    chemokine CXCL1 released from tumour epithelial cells stimulates endothelial cell
    migration and tube formation in vitro and angiogenesis in vivo. CCL2 can attract
    endothelial cells to the tumour microenvironment. Interestingly, VEGF and FGF2
    induce COX2 and subsequently PGE2 in endothelial cells, and CCL2 also induces
    COX2 and PGE2 in macrophages. Therefore, the effects of PGE2 on the regulation
    of VEGF, FGF2 and CCL2 are probably amplified through this positive feedback loop.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FGF21
  - FGF2
  - MAPK3
  - FGF7
  - FGF22
  - FGF6
  - FLT1
  - FGF17
  - FGF8
  - MAPK1
  - FGF18
  - FGF13
  - FGF14
  - FGF23
  - FGF12
  - FGFR3
  - FLT4
  - FGF1
  - TFPI
  - FGF4
  - FGF5
  - RAC1
  - FGF3
  - FGF11
  - FGF10
  - FGFR1
  - FGF20
  - VEGFB
  - VEGFC
  - FGFR2
  - CXCR4
  - LTB
  - RHOG
  - KDR
  - VEGFD
  - FGF16
  - FGF9
  - CCL2
  - PGF
  - VEGFA
  - EGFR
  - RAC3
  - CDC42
  - FGFR4
  - FGFRL1
  - RAC2
  - FGF19
  - PGE
  - Cancer
genes:
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF21
  entrez: '26291'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF2
  entrez: '2247'
- word: Erk
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF7
  entrez: '2252'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF22
  entrez: '27006'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF6
  entrez: '2251'
- word: VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: FLT1
  entrez: '2321'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF17
  entrez: '8822'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF8
  entrez: '2253'
- word: Erk
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF18
  entrez: '8817'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF13
  entrez: '2258'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF14
  entrez: '2259'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF23
  entrez: '8074'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF12
  entrez: '2257'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR3
  entrez: '2261'
- word: VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: FLT4
  entrez: '2324'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF1
  entrez: '2246'
- word: EPI
  symbol: EPI
  source: hgnc_alias_symbol
  hgnc_symbol: TFPI
  entrez: '7035'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF4
  entrez: '2249'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF5
  entrez: '2250'
- word: Rac
  symbol: RAC
  source: bioentities_symbol
  hgnc_symbol: RAC1
  entrez: '5879'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF3
  entrez: '2248'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF11
  entrez: '2256'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF10
  entrez: '2255'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR1
  entrez: '2260'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF20
  entrez: '26281'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR2
  entrez: '2263'
- word: CXCR4
  symbol: CXCR4
  source: hgnc_symbol
  hgnc_symbol: CXCR4
  entrez: '7852'
- word: LTB,
  symbol: LTB
  source: hgnc_symbol
  hgnc_symbol: LTB
  entrez: '4050'
- word: Rac
  symbol: RAC
  source: bioentities_symbol
  hgnc_symbol: RHOG
  entrez: '391'
- word: VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: KDR
  entrez: '3791'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF16
  entrez: '8823'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF9
  entrez: '2254'
- word: FGF2
  symbol: FGF2
  source: hgnc_symbol
  hgnc_symbol: FGF2
  entrez: '2247'
- word: CCL2
  symbol: CCL2
  source: hgnc_symbol
  hgnc_symbol: CCL2
  entrez: '6347'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: Rac
  symbol: RAC
  source: bioentities_symbol
  hgnc_symbol: RAC3
  entrez: '5881'
- word: CDC42)
  symbol: CDC42
  source: hgnc_symbol
  hgnc_symbol: CDC42
  entrez: '998'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR4
  entrez: '2264'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFRL1
  entrez: '53834'
- word: Rac
  symbol: RAC
  source: bioentities_symbol
  hgnc_symbol: RAC2
  entrez: '5880'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF19
  entrez: '9965'
chemicals:
- word: PGE
  source: MESH
  identifier: D011458
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC2898136__F6
redirect_from: /figures/PMC2898136__F6
figtype: Figure
---
